Ideal for non-Scientists and Scientists who need to understand the
basic theory, principles, techniques, and potential of biotechnology
This intensive three-day course is ideal for non-scientists and
scientists needing to understand the basic theory, principles,
techniques and potential of biotechnology.
You will gain an overview of how biotech products are being developed
and manufactured, and discuss the scientific and regulatory environment.
The latest advances in regulation will be covered, including biosimilars
and advanced therapies. The course will also discuss the role and
importance of patents within biotech, including what actually can be
patented.
Why Should You Attend?
Gain an introduction to the fundamental principles of Biotechnology
Improve your understanding of the key techniques used by
Biotechnologists
Understand the importance of meeting regulatory requirements and hear
about the advances being made
Learn how to identify potential patents, and why and how they must be
protected
Who Should Attend
Quality Assurance
Regulatory Affairs
Legal and IP
Business Development
Sales and Marketing
Engineering
Finance
Training
Administration
Management
Agenda
Programme Day one
Introduction to Biotechnology
Historical perspective
Diversity of biotechnology products
Impact on society
Product development overview
Introduction to Molecular Biology
DNA, RNA, genes, plasmids, and vectors
Protein synthesis - transcription and translation
Re-Expression of Proteins
Recombinant DNA techniques
Monoclonal antibodies - from mouse to human
Transgenic animals and plants
Development of Production Organisms
Transfection
Selection
Preservation
Fermentation Technology and Large Scale Production
Types of fermenters
Fermentation basics
Modes of operation
Process development
General Discussion
End of Day One and Drinks Reception
Programme Day two
Process Optimisation and Scale-Up
Scale-up strategies
Strain improvement
Media improvement
Process improvement
Analysis of Biopharmaceuticals
Biological activity
Physicochemical characterisation
Purity, impurities and contaminants
Product Recovery and Purification
Cell harvesting and removal
Clarification - intracellular and extracellular proteins
Chromatographic techniques
Formulation Design of Biopharmaceuticals
Factors affecting degradation
Choice of excipients
Prolonging shelf life
Process Economics
Drug development and bioprocess economics
Optimising bioprocess economics
Manufacturing make or buy
Future manufacturing alternatives
General Discussion
Programme Day three
Patenting Biotech Inventions
What is a patent?
What are the basic criteria for patentability?
What can be patented?
Can you patent genes, proteins, hybridomas, and stem cells?
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland.
The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance --
2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme").
For this purpose, Sobi has prepared a base prospectus, which...